These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22820853)

  • 21. Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis.
    Lee YH; Woo JH; Choi SJ; Ji JD; Song GG
    Lupus; 2010 May; 19(6):703-10. PubMed ID: 20064907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis.
    Zhou T; Lin S; Yang S; Lin W
    Drug Des Devel Ther; 2019; 13():857-869. PubMed ID: 30880918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multitarget therapy versus monotherapy as induction treatment for lupus nephritis: A meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Lupus; 2022 Oct; 31(12):1468-1476. PubMed ID: 35986446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Sakai R; Kurasawa T; Nishi E; Kondo T; Okada Y; Shibata A; Nishimura K; Chino K; Okuyama A; Takei H; Nagasawa H; Amano K
    Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term outcomes of induction therapy with tacrolimus versus cyclophosphamide for active lupus nephritis: A multicenter randomized clinical trial.
    Chen W; Tang X; Liu Q; Chen W; Fu P; Liu F; Liao Y; Yang Z; Zhang J; Chen J; Lou T; Fu J; Kong Y; Liu Z; Fan A; Rao S; Li Z; Yu X
    Am J Kidney Dis; 2011 Feb; 57(2):235-44. PubMed ID: 21177013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multitarget Therapy: An Effective and Safe Therapeutic Regimen for Lupus Nephritis.
    Zhou T; Zhang X; Lin W; Lin S
    J Pharm Pharm Sci; 2019; 22(1):365-375. PubMed ID: 31580800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
    Feng X; Gu F; Chen W; Liu Y; Wei H; Liu L; Yin S; Da Z; Sun L
    Chin Med J (Engl); 2014; 127(21):3718-23. PubMed ID: 25382325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction and Maintenance Immunosuppression Treatment of Proliferative Lupus Nephritis: A Network Meta-analysis of Randomized Trials.
    Palmer SC; Tunnicliffe DJ; Singh-Grewal D; Mavridis D; Tonelli M; Johnson DW; Craig JC; Tong A; Strippoli GFM
    Am J Kidney Dis; 2017 Sep; 70(3):324-336. PubMed ID: 28233655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study.
    Mehra S; Usdadiya JB; Jain VK; Misra DP; Negi VS
    Rheumatol Int; 2018 Apr; 38(4):557-568. PubMed ID: 29450636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycophenolate mofetil is as efficacious as, but safer than, cyclophosphamide in the treatment of proliferative lupus nephritis: a meta-analysis and meta-regression.
    Mak A; Cheak AA; Tan JY; Su HC; Ho RC; Lau CS
    Rheumatology (Oxford); 2009 Aug; 48(8):944-52. PubMed ID: 19494179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of tacrolimus therapy for lupus nephritis: a systematic review of clinical trials.
    Lee YH; Lee HS; Choi SJ; Dai Ji J; Song GG
    Lupus; 2011 May; 20(6):636-40. PubMed ID: 21382917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.
    Mok CC
    Nephrol Dial Transplant; 2016 Oct; 31(10):1561-6. PubMed ID: 27591327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB; Won S; Bae SC
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment for lupus nephritis.
    Flanc RS; Roberts MA; Strippoli GF; Chadban SJ; Kerr PG; Atkins RC
    Cochrane Database Syst Rev; 2004; (1):CD002922. PubMed ID: 14973998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
    Kagawa H; Hiromasa T; Hara T; Takaki A; Yamanaka R; Sada KE; Makino H
    Clin Exp Nephrol; 2012 Oct; 16(5):760-6. PubMed ID: 22492013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of induction treatment in Thai patients with lupus nephritis: Observational cohort analysis.
    Pichaiwong W; Lawanaskol S; Phinyo P; Kitumnuaypong T
    Lupus; 2023 Mar; 32(3):444-452. PubMed ID: 36602394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A network meta-analysis of randomized controlled trials comparing the effectiveness and safety of voclosporin or tacrolimus plus mycophenolate mofetil as induction treatment for lupus nephritis.
    Lee YH; Song GG
    Z Rheumatol; 2023 Sep; 82(7):580-586. PubMed ID: 34545430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Efficacy and Safety of Leflunomide for the Treatment of Lupus Nephritis in Chinese Patients: Systematic Review and Meta-Analysis.
    Cao H; Rao Y; Liu L; Lin J; Yang H; Zhang X; Chen Z
    PLoS One; 2015; 10(12):e0144548. PubMed ID: 26670616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.